Kiriyama Akiko, Honbo Akino, Nishimura Asako, Shibata Nobuhito, Iga Katsumi
Department of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, Kodo, Kyotanabe, Kyoto, 610-0395, Japan.
Department of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts, Kodo, Kyotanabe, Kyoto, 610-0395, Japan.
Regul Toxicol Pharmacol. 2016 Apr;76:21-9. doi: 10.1016/j.yrtph.2016.01.003. Epub 2016 Jan 7.
To investigate the relationship between the pharmacokinetics (PK) and effects and/or side-effects of nifedipine and propranolol, simultaneous examination of their PK and pharmacodynamics (PD), namely blood pressure (BP), heart rate (HR), and QT interval (QT), were assessed in spontaneously hypertensive rats as a disease model. Drugs were infused intravenously for 30 min, then plasma PK and hemodynamic effects were monitored. After general two-compartmental analysis was applied to the plasma data, PD parameters were calculated by fitting the data to PK-PD models. After nifedipine administration, the maximal hypotensive effect appeared about 10 min after starting the infusion, then BP started to elevate although the plasma concentration increased, supposedly because of a negative feedback mechanism generated from the homeostatic mechanism. After propranolol administration, HR decreased by half, and this bradycardic effect was greater than that with nifedipine. Wide variation in QT was observed when the propranolol concentration exceeded 700 ng/mL. This variation may have been caused by arrhythmia. Prolongation of QT with propranolol was greater than that with nifedipine, and bradycardia was slower than the concentration increase and QT prolongation. The characteristically designed PK-PD model incorporating a negative feedback system could be adequately and simultaneously fitted to both observed effect and side-effects.
为研究硝苯地平和普萘洛尔的药代动力学(PK)与效应和/或副作用之间的关系,以自发性高血压大鼠作为疾病模型,对其PK和药效学(PD),即血压(BP)、心率(HR)和QT间期(QT)进行了同步检测。药物静脉输注30分钟,然后监测血浆PK和血流动力学效应。对血浆数据应用一般的二室分析后,通过将数据拟合到PK-PD模型来计算PD参数。给予硝苯地平后,最大降压效应在开始输注后约10分钟出现,然后尽管血浆浓度升高,但血压开始升高,推测这是由于稳态机制产生的负反馈机制所致。给予普萘洛尔后,心率减半,这种心动过缓效应比硝苯地平更明显。当普萘洛尔浓度超过700 ng/mL时,观察到QT有很大变化。这种变化可能是由心律失常引起的。普萘洛尔导致的QT延长比硝苯地平更明显,心动过缓比浓度升高和QT延长更缓慢。结合负反馈系统的特殊设计的PK-PD模型能够充分且同时拟合观察到的效应和副作用。